Simbec-Orion   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Merthyr Tydfil United Kingdom (1974)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2000
NCT00004219
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Seirian-Simbec | Simbec Orion | Simbec-Orion Clinical Pharmacology | Simbec Research | Simbec Research Ltd (Simbec) | SimbecRresearch Ltd.